152 related articles for article (PubMed ID: 24623386)
1. Detection of CFTR protein in human leukocytes by flow cytometry.
Johansson J; Vezzalini M; Verzè G; Caldrer S; Bolognin S; Buffelli M; Bellisola G; Tridello G; Assael BM; Melotti P; Sorio C
Cytometry A; 2014 Jul; 85(7):611-20. PubMed ID: 24623386
[TBL] [Abstract][Full Text] [Related]
2. Ataluren (PTC124) induces cystic fibrosis transmembrane conductance regulator protein expression and activity in children with nonsense mutation cystic fibrosis.
Sermet-Gaudelus I; Boeck KD; Casimir GJ; Vermeulen F; Leal T; Mogenet A; Roussel D; Fritsch J; Hanssens L; Hirawat S; Miller NL; Constantine S; Reha A; Ajayi T; Elfring GL; Miller LL
Am J Respir Crit Care Med; 2010 Nov; 182(10):1262-72. PubMed ID: 20622033
[TBL] [Abstract][Full Text] [Related]
3. Electrophysiological evaluation of cystic fibrosis conductance transmembrane regulator (CFTR) expression in human monocytes.
Ettorre M; Verzè G; Caldrer S; Johansson J; Calcaterra E; Assael BM; Melotti P; Sorio C; Buffelli M
Biochim Biophys Acta; 2014 Oct; 1840(10):3088-95. PubMed ID: 25046381
[TBL] [Abstract][Full Text] [Related]
4. mGluR1 interacts with cystic fibrosis transmembrane conductance regulator and modulates the secretion of IL-10 in cystic fibrosis peripheral lymphocytes.
Shanshiashvili LV; Dabrundashvili N; Natsvlishvili N; Kvaratskhelia E; Zhuravliova E; Barbakadze T; Koriauli S; Maisuradze E; Topuria T; Mikeladze DG
Mol Immunol; 2012 Jul; 51(3-4):310-5. PubMed ID: 22520513
[TBL] [Abstract][Full Text] [Related]
5. Mutations of Cystic Fibrosis Transmembrane Conductance Regulator Gene Cause a Monocyte-Selective Adhesion Deficiency.
Sorio C; Montresor A; Bolomini-Vittori M; Caldrer S; Rossi B; Dusi S; Angiari S; Johansson JE; Vezzalini M; Leal T; Calcaterra E; Assael BM; Melotti P; Laudanna C
Am J Respir Crit Care Med; 2016 May; 193(10):1123-33. PubMed ID: 26694899
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of premature stop codon readthrough in the CFTR gene by Ataluren (PTC124) derivatives.
Pibiri I; Lentini L; Melfi R; Gallucci G; Pace A; Spinello A; Barone G; Di Leonardo A
Eur J Med Chem; 2015 Aug; 101():236-44. PubMed ID: 26142488
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial.
Kerem E; Hirawat S; Armoni S; Yaakov Y; Shoseyov D; Cohen M; Nissim-Rafinia M; Blau H; Rivlin J; Aviram M; Elfring GL; Northcutt VJ; Miller LL; Kerem B; Wilschanski M
Lancet; 2008 Aug; 372(9640):719-27. PubMed ID: 18722008
[TBL] [Abstract][Full Text] [Related]
8. Defective CFTR expression and function are detectable in blood monocytes: development of a new blood test for cystic fibrosis.
Sorio C; Buffelli M; Angiari C; Ettorre M; Johansson J; Vezzalini M; Viviani L; Ricciardi M; Verzè G; Assael BM; Melotti P
PLoS One; 2011; 6(7):e22212. PubMed ID: 21811577
[TBL] [Abstract][Full Text] [Related]
9. Chronic ataluren (PTC124) treatment of nonsense mutation cystic fibrosis.
Wilschanski M; Miller LL; Shoseyov D; Blau H; Rivlin J; Aviram M; Cohen M; Armoni S; Yaakov Y; Pugatsch T; Cohen-Cymberknoh M; Miller NL; Reha A; Northcutt VJ; Hirawat S; Donnelly K; Elfring GL; Ajayi T; Kerem E
Eur Respir J; 2011 Jul; 38(1):59-69. PubMed ID: 21233271
[TBL] [Abstract][Full Text] [Related]
10. Optimal complement-mediated phagocytosis of Pseudomonas aeruginosa by monocytes is cystic fibrosis transmembrane conductance regulator-dependent.
Van de Weert-van Leeuwen PB; Van Meegen MA; Speirs JJ; Pals DJ; Rooijakkers SH; Van der Ent CK; Terheggen-Lagro SW; Arets HG; Beekman JM
Am J Respir Cell Mol Biol; 2013 Sep; 49(3):463-70. PubMed ID: 23617438
[TBL] [Abstract][Full Text] [Related]
11. Cystic fibrosis transmembrane conductance regulator channel dysfunction in non-cystic fibrosis bronchiectasis.
Bienvenu T; Sermet-Gaudelus I; Burgel PR; Hubert D; Crestani B; Bassinet L; Dusser D; Fajac I
Am J Respir Crit Care Med; 2010 May; 181(10):1078-84. PubMed ID: 20167849
[TBL] [Abstract][Full Text] [Related]
12. CFTR genotype and clinical outcomes of adult patients carried as cystic fibrosis disease.
Bonadia LC; de Lima Marson FA; Ribeiro JD; Paschoal IA; Pereira MC; Ribeiro AF; Bertuzzo CS
Gene; 2014 May; 540(2):183-90. PubMed ID: 24583165
[TBL] [Abstract][Full Text] [Related]
13. Severe deficiency of cystic fibrosis transmembrane conductance regulator messenger RNA carrying nonsense mutations R553X and W1316X in respiratory epithelial cells of patients with cystic fibrosis.
Hamosh A; Trapnell BC; Zeitlin PL; Montrose-Rafizadeh C; Rosenstein BJ; Crystal RG; Cutting GR
J Clin Invest; 1991 Dec; 88(6):1880-5. PubMed ID: 1721624
[TBL] [Abstract][Full Text] [Related]
14. Misprocessing of the CFTR protein leads to mild cystic fibrosis phenotype.
Clain J; Lehmann-Che J; Duguépéroux I; Arous N; Girodon E; Legendre M; Goossens M; Edelman A; de Braekeleer M; Teulon J; Fanen P
Hum Mutat; 2005 Apr; 25(4):360-71. PubMed ID: 15776432
[TBL] [Abstract][Full Text] [Related]
15. Intestinal current measurement for diagnostic classification of patients with questionable cystic fibrosis: validation and reference data.
Derichs N; Sanz J; Von Kanel T; Stolpe C; Zapf A; Tümmler B; Gallati S; Ballmann M
Thorax; 2010 Jul; 65(7):594-9. PubMed ID: 20627915
[TBL] [Abstract][Full Text] [Related]
16. Evidence that systemic gentamicin suppresses premature stop mutations in patients with cystic fibrosis.
Clancy JP; Bebök Z; Ruiz F; King C; Jones J; Walker L; Greer H; Hong J; Wing L; Macaluso M; Lyrene R; Sorscher EJ; Bedwell DM
Am J Respir Crit Care Med; 2001 Jun; 163(7):1683-92. PubMed ID: 11401894
[TBL] [Abstract][Full Text] [Related]
17. Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations.
Wilschanski M; Yahav Y; Yaacov Y; Blau H; Bentur L; Rivlin J; Aviram M; Bdolah-Abram T; Bebok Z; Shushi L; Kerem B; Kerem E
N Engl J Med; 2003 Oct; 349(15):1433-41. PubMed ID: 14534336
[TBL] [Abstract][Full Text] [Related]
18. Regulation of cystic fibrosis transmembrane conductance regulator by microRNA-145, -223, and -494 is altered in ΔF508 cystic fibrosis airway epithelium.
Oglesby IK; Chotirmall SH; McElvaney NG; Greene CM
J Immunol; 2013 Apr; 190(7):3354-62. PubMed ID: 23436935
[TBL] [Abstract][Full Text] [Related]
19. Transient receptor potential canonical channel 6 links Ca2+ mishandling to cystic fibrosis transmembrane conductance regulator channel dysfunction in cystic fibrosis.
Antigny F; Norez C; Dannhoffer L; Bertrand J; Raveau D; Corbi P; Jayle C; Becq F; Vandebrouck C
Am J Respir Cell Mol Biol; 2011 Jan; 44(1):83-90. PubMed ID: 20203293
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the CFTR gene in Iranian cystic fibrosis patients: identification of eight novel mutations.
Alibakhshi R; Kianishirazi R; Cassiman JJ; Zamani M; Cuppens H
J Cyst Fibros; 2008 Mar; 7(2):102-9. PubMed ID: 17662673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
